Entasobulin (E412371): Mechanism, Use & Lab Guidelines
Entasobulin (E412371): Mechanism, Use & Lab Guidelines
Entasobulin is a potent small-molecule inhibitor that targets tubulin polymerization, disrupting mitotic spindle formation and inducing apoptosis in cancer cells, making it a valuable tool compound for preclinical oncology research.
- Product Name
- Entasobulin
- SKU / Catalog Number
- E412371
- Selleck Number
- S0417
- Compound Class
- Tubulin polymerization inhibitor (microtubule-targeting agent)
- Primary Research Application
- Preclinical oncology; mitosis and apoptosis studies
- Recommended Storage
- Store at -20 °C, protected from light and moisture; verify with product datasheet
Mechanism of Action
Entasobulin (E412371) is a small-molecule agent classified as a tubulin polymerization inhibitor. It exerts its antiproliferative effects by binding to tubulin, the structural protein subunit that assembles into microtubules. Microtubules are essential cytoskeletal elements that form the mitotic spindle during cell division; their dynamic instability is critical for proper chromosome segregation.
By inhibiting the polymerization of α/β-tubulin heterodimers into functional microtubule polymers, Entasobulin arrests cells in the G2/M phase of the cell cycle. Prolonged mitotic arrest triggers the intrinsic apoptotic pathway, leading to programmed cell death preferentially in rapidly dividing tumor cells. This mechanism is analogous to other well-characterized microtubule-targeting agents, though the precise binding site and binding kinetics of Entasobulin should be confirmed against primary literature before use in mechanistic studies.
Physicochemical Properties and Solubility
Accurate knowledge of a compound's physicochemical properties is prerequisite to designing reproducible assays. For Entasobulin, researchers should consult the official Aladdin product datasheet (SKU E412371) and the corresponding Selleck entry (S0417) for the confirmed molecular formula, molecular weight, purity specification, and appearance.
As a general guideline for tubulin inhibitors of this class, stock solutions are typically prepared in dimethyl sulfoxide (DMSO) at concentrations of 10–50 mM. The final DMSO concentration in cell-based assays should not exceed 0.1% (v/v) to avoid solvent cytotoxicity artifacts. Aqueous solubility is generally limited; therefore, working dilutions should be prepared fresh in pre-warmed, serum-containing culture medium to minimize precipitation. Always perform a visual clarity check before adding compound to cells. Specific solubility values and recommended vehicle systems must be verified on the product datasheet, as formulation requirements vary between batches and experimental contexts.
Laboratory Handling, Storage, and Safety Guidelines
Storage: Entasobulin should be stored at -20 °C in a tightly sealed vial, protected from light and moisture. Repeated freeze-thaw cycles degrade compound integrity; aliquot the stock solution into single-use volumes upon first reconstitution. Long-term stability data should be verified against the certificate of analysis supplied with each lot.
Personal Protective Equipment (PPE): As with all research-grade cytotoxic compounds, handle Entasobulin inside a certified chemical fume hood or biological safety cabinet. Wear nitrile gloves (double-glove recommended), a laboratory coat, and safety glasses. Avoid inhalation of powders or aerosols. Consult the Safety Data Sheet (SDS) for E412371 before first use; SDS documents are available from Aladdin Scientific upon request.
Waste Disposal: Dispose of Entasobulin-containing waste in accordance with local institutional and national regulations for cytotoxic chemical waste. Do not dispose of solutions via standard drain or general laboratory waste streams.
Experimental Applications and Assay Design Considerations
Entasobulin is primarily employed in in vitro and in vivo preclinical oncology studies. Typical research applications include:
- Antiproliferative assays: Dose-response studies in cancer cell lines using MTT, CellTiter-Glo, or similar viability readouts to determine IC50 values. Include vehicle (DMSO) controls and a reference tubulin inhibitor as a positive control.
- Cell cycle analysis: Flow cytometric assessment of propidium iodide (PI)-stained cells to quantify G2/M arrest following Entasobulin treatment at defined concentrations and time points.
- Apoptosis assays: Annexin V/PI double-staining or caspase activation assays to confirm apoptotic cell death downstream of mitotic arrest.
- Immunofluorescence microscopy: Anti-α-tubulin staining to visualize microtubule network disruption in treated cells versus vehicle controls.
- In vivo xenograft models: Subcutaneous or orthotopic tumor models in immunodeficient mice; dosing regimen, formulation, and route of administration should be established based on published pharmacokinetic data where available.
Always run appropriate solvent controls at matched DMSO concentrations. Establish a concentration range spanning at least three orders of magnitude for IC50 determination. Validate compound activity in at least two independent cell lines before drawing mechanistic conclusions.
Quality, Ordering, and Regulatory Notes
Purity and QC: Aladdin Scientific supplies Entasobulin (E412371) as a research-grade reagent. Each lot is accompanied by a certificate of analysis (CoA) specifying purity (typically assessed by HPLC), identity (confirmed by NMR or MS), and appearance. Researchers should request the CoA at the time of order and retain it for experimental records.
Ordering: Entasobulin can be ordered directly from Aladdin Scientific using catalog number E412371. Cross-reference with Selleck number S0417 when comparing data from external sources. Contact Aladdin Scientific customer support for bulk quantities, custom formulations, or expedited shipping requirements.
Regulatory status: Entasobulin is supplied strictly for in vitro and in vivo research purposes only. It is not approved for human therapeutic use and must not be used in clinical, diagnostic, or veterinary applications without appropriate regulatory authorization. Users are responsible for ensuring compliance with all applicable institutional biosafety, chemical safety, and export control regulations.
Frequently asked questions
What is Entasobulin and what is it used for in research?
Entasobulin (E412371) is a small-molecule tubulin polymerization inhibitor used as a research tool compound in preclinical oncology studies. It is applied in antiproliferative assays, cell cycle analysis, apoptosis studies, and immunofluorescence experiments to investigate microtubule-dependent cellular processes in cancer models.
How should Entasobulin stock solutions be prepared and stored?
Entasobulin (E412371) stock solutions are typically prepared by dissolving the compound in DMSO to a concentration of 10–50 mM, followed by aliquoting into single-use volumes to avoid freeze-thaw degradation. Vials should be stored at -20 °C, sealed, and protected from light and moisture. Always consult the product datasheet and CoA for lot-specific solubility and stability data.
What controls should be included when running Entasobulin cell-based assays?
All Entasobulin (E412371) cell-based assays should include a vehicle control (DMSO at the same final concentration as the treatment groups, not exceeding 0.1% v/v), an untreated negative control, and ideally a positive control using a well-characterized reference tubulin inhibitor. Running dose-response curves across at least three orders of magnitude and validating results in multiple cell lines improves data reliability.
Is Entasobulin approved for clinical or therapeutic use?
No. Entasobulin (E412371) is supplied by Aladdin Scientific exclusively as a research-grade reagent for in vitro and in vivo preclinical research purposes. It is not approved for human therapeutic, clinical diagnostic, or veterinary use. Researchers must comply with all relevant institutional and national regulations when handling this compound.
References
- Selleck Chemicals. Entasobulin (S0417) product information. Selleck Chemicals LLC.
- Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nature Reviews Cancer. 2004;4(4):253-265.
- Aladdin Scientific. Entasobulin (E412371) product datasheet and certificate of analysis. Aladdin Scientific.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
